Correlation of Retinal and Choroidal Microvascular Impairment in Systemic Sclerosis

Overview

Journal Orphanet J Rare Dis

Publisher Biomed Central

Specialty General Medicine

Date 2021 Jan 14

PMID 33441156

Citations 14

Authors

Felix Rommel

David Prangel

Michelle Prasuhn

Salvatore Grisanti

Mahdy Ranjbar

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the correlation between retinal and choroidal microperfusion in patients with systemic sclerosis (SSc) using optical coherence tomography angiography (OCTA).

Methods: In this cross-sectional study SSc patients without clinical evidence of ocular involvement and healthy, age- and sex-matched volunteers were recruited. Participants underwent specific rheumatological and ophthalmological examinations, including optical coherence tomography (OCT) and OCTA. Retinal and choroidal thicknesses as well as perfusion of the retina and the choroidal sublayers were evaluated.

Results: A total of 15 SSc patients (30 eyes) with a median disease duration of 60 months and 15 matched, healthy controls (30 eyes) were recruited. OCT data revealed a significantly lower macular volume, as well as Sattler's layer and Haller's layer thickness in SSc patients compared to controls. In OCTA analysis, the perfusion of both retinal plexus as well as Sattler's and Haller's layer were significantly reduced in the SSc group. Patients with a disease duration of more than 60 months showed a statistically significant positive correlation between retinal and choroidal malperfusion, while those with a shorter disease duration did not.

Conclusion: OCTA analysis confirmed impairment of retinal and choroidal microperfusion in SSc patients, supporting the hypothesis of wide spreading vascular injury. In early stages, either the retinal or the choroidal perfusion seems to be involved, while later on, vascular impairment affects both tissues alike. Both, retinal and choroidal examinations should be considered as soon as the diagnosis of SSc is made, to avoid missing out on early alterations.

Citing Articles

Extrapulmonary manifestations of pulmonary arterial hypertension.

Singh N, Al-Naamani N, Brown M, Long G, Thenappan T, Umar S Expert Rev Respir Med. 2024; 18(3-4):189-205.

PMID: 38801029 PMC: 11713041. DOI: 10.1080/17476348.2024.2361037.

Ocular Manifestation in Systemic Sclerosis-A Literature Review.

Paczwa K, Rerych M, Romanowska-Prochnicka K, Rozycki R, Golebiewska J Life (Basel). 2024; 14(5).

PMID: 38792647 PMC: 11122095. DOI: 10.3390/life14050627.

Retinal Vascular Abnormalities and Clinical Parameters in Systemic Sclerosis.

Foti R, Zeppieri M, Foti R, Visalli E, Amato G, Amato R J Clin Med. 2024; 13(10).

PMID: 38792282 PMC: 11122651. DOI: 10.3390/jcm13102738.

Macular choroidal thickness, volume, and vascularity index in patients with systemic sclerosis.

Pieklarz B, Gindzienska-Sieskiewicz E, Zawadzka I, Bagrowska M, Daniluk J, Palewski M Graefes Arch Clin Exp Ophthalmol. 2023; 262(5):1475-1487.

PMID: 38133798 PMC: 11031445. DOI: 10.1007/s00417-023-06342-4.

Retinal microvascular and microstructural alterations in the diagnosis of meibomian gland dysfunction in severely obese population: a new approach.

Huang H, Wang X, Wei H, Kang M, Zou J, Ling Q Int J Ophthalmol. 2023; 16(12):1977-1985.

PMID: 38111945 PMC: 10700072. DOI: 10.18240/ijo.2023.12.09.

References

Rabquer B, Koch A . Angiogenesis and vasculopathy in systemic sclerosis: evolving concepts. Curr Rheumatol Rep. 2011; 14(1):56-63. DOI: 10.1007/s11926-011-0219-1. View

Gilbane A, Denton C, Holmes A . Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther. 2013; 15(3):215. PMC: 4060542. DOI: 10.1186/ar4230. View

Trojanowska M . Cellular and molecular aspects of vascular dysfunction in systemic sclerosis. Nat Rev Rheumatol. 2010; 6(8):453-60. PMC: 3824624. DOI: 10.1038/nrrheum.2010.102. View

Laties A . Central retinal artery innervation. Absence of adrenergic innervation to the intraocular branches. Arch Ophthalmol. 1967; 77(3):405-9. DOI: 10.1001/archopht.1967.00980020407021. View

Ranjbar M, Rothe M, Klapa S, Lange T, Prasuhn M, Grisanti S . Evaluation of choroidal substructure perfusion in patients affected by systemic sclerosis: an optical coherence tomography angiography study. Scand J Rheumatol. 2019; 49(2):141-145. DOI: 10.1080/03009742.2019.1641616. View

Valentini G, Cuomo G, Abignano G, Petrillo A, Vettori S, Capasso A . Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology (Oxford). 2010; 50(2):317-23. DOI: 10.1093/rheumatology/keq176. View

Kim M, Kim S, Kwon H, Koh H, Lee S . Association between choroidal thickness and ocular perfusion pressure in young, healthy subjects: enhanced depth imaging optical coherence tomography study. Invest Ophthalmol Vis Sci. 2012; 53(12):7710-7. DOI: 10.1167/iovs.12-10464. View

Esen E, Tas D, Sizmaz S, Turk I, Unal I, Demircan N . Evaluating Choroidal Characteristics in Systemic Sclerosis Using Enhanced Depth Imaging Optical Coherence Tomography. Ocul Immunol Inflamm. 2016; 25(3):356-362. DOI: 10.3109/09273948.2015.1129424. View

Kilinc Hekimsoy H, Sekeroglu M, Kocer A, Akdogan A . Analysis of retinal and choroidal microvasculature in systemic sclerosis: an optical coherence tomography angiography study. Eye (Lond). 2019; 34(4):763-770. PMC: 7093531. DOI: 10.1038/s41433-019-0591-z. View

10.

Siegfried F, Rommel F, Rothe M, Brinkmann M, Sochurek J, Freitag J . Evaluating diurnal changes in choroidal sublayer perfusion using optical coherence tomography angiography. Acta Ophthalmol. 2019; 97(8):e1062-e1068. DOI: 10.1111/aos.14140. View

11.

Ranjbar M, Prasuhn M, Kurz M, Holzhey A, Rommel F, Brinkmann M . Subfoveal choriocapillaris, Sattler's and Haller's layer thickness predict clinical response to stereotactic radiotherapy in neovascular age-related macular degeneration patients. J Curr Ophthalmol. 2019; 31(1):92-94. PMC: 6407312. DOI: 10.1016/j.joco.2018.12.004. View

12.

. Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology. 1991; 98(5 Suppl):786-806. View

13.

Sebastiani M, Manfredi A, Colaci M, DAmico R, Malagoli V, Giuggioli D . Capillaroscopic skin ulcer risk index: a new prognostic tool for digital skin ulcer development in systemic sclerosis patients. Arthritis Rheum. 2009; 61(5):688-94. DOI: 10.1002/art.24394. View

14.

Rothe M, Rommel F, Klapa S, Humrich J, Nieberding R, Lange T . Evaluation of retinal microvascular perfusion in systemic sclerosis: a case-control study. Ann Rheum Dis. 2019; 78(6):857-858. DOI: 10.1136/annrheumdis-2018-214541. View

15.

Ingegnoli F, Gualtierotti R, Pierro L, Del Turco C, Miserocchi E, Schioppo T . Choroidal impairment and macular thinning in patients with systemic sclerosis: the acute study. Microvasc Res. 2014; 97:31-6. DOI: 10.1016/j.mvr.2014.08.008. View

16.

Bill A . Blood circulation and fluid dynamics in the eye. Physiol Rev. 1975; 55(3):383-417. DOI: 10.1152/physrev.1975.55.3.383. View

17.

Luo X, Shen Y, Jiang M, Lou X, Shen Y . Ocular Blood Flow Autoregulation Mechanisms and Methods. J Ophthalmol. 2015; 2015:864871. PMC: 4631905. DOI: 10.1155/2015/864871. View

18.

Allanore Y, Simms R, Distler O, Trojanowska M, Pope J, Denton C . Systemic sclerosis. Nat Rev Dis Primers. 2016; 1:15002. DOI: 10.1038/nrdp.2015.2. View

19.

Gomes B, Santhiago M, Magalhaes P, Kara-Junior N, Azevedo M, Moraes Jr H . Ocular findings in patients with systemic sclerosis. Clinics (Sao Paulo). 2011; 66(3):379-85. PMC: 3071995. DOI: 10.1590/s1807-59322011000300003. View

20.

Ferreira C, Beato J, Falcao M, Brandao E, Falcao-Reis F, Carneiro A . CHOROIDAL THICKNESS IN MULTISYSTEMIC AUTOIMMUNE DISEASES WITHOUT OPHTHALMOLOGIC MANIFESTATIONS. Retina. 2016; 37(3):529-535. DOI: 10.1097/IAE.0000000000001193. View